(Q37996445)

English

Effective lifestyle interventions to improve type II diabetes self-management for those with schizophrenia or schizoaffective disorder: a systematic review

scientific article published on 23 March 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 August 2017

1 reference

4 February 2021

systematic review

1 reference

Effective lifestyle interventions to improve type II diabetes self-management for those with schizophrenia or schizoaffective disorder: a systematic review (English)

1 reference

Europe PubMed Central

26 August 2017

1 reference

2 August 2020

type 2 diabetes

1 reference

4 February 2021

1 reference

2 August 2020

1 reference

2 August 2020

1 reference

5 December 2020

systematic review

1 reference

based on heuristic

inferred from title

schizoaffective disorder

1 reference

based on heuristic

inferred from title

5

object named as

Carolyn S Dewa

1 reference

Europe PubMed Central

26 August 2017

4

object named as

Sarah Bonato

1 reference

Europe PubMed Central

26 August 2017

Erene Stergiopoulos

2

object named as

Erene Stergiopoulos

1 reference

Europe PubMed Central

26 August 2017

author name string

Adriana Cimo

1

1 reference

Europe PubMed Central

26 August 2017

Chiachen Cheng

3

1 reference

Europe PubMed Central

26 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

23 March 2012

8 references

Europe PubMed Central

26 August 2017

13 March 2019

14 March 2019

24 March 2019

25 June 2019

2 August 2020

5 December 2020

4 February 2021

8 references

Europe PubMed Central

26 August 2017

13 March 2019

14 March 2019

24 March 2019

25 June 2019

2 August 2020

5 December 2020

4 February 2021

12

1 reference

Europe PubMed Central

26 August 2017

24

1 reference

Europe PubMed Central

26 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

7 references

Europe PubMed Central

13 March 2019

Europe PubMed Central

14 March 2019

Europe PubMed Central

24 March 2019

Europe PubMed Central

25 June 2019

Europe PubMed Central

2 August 2020

Europe PubMed Central

5 December 2020

Europe PubMed Central

4 February 2021

copyright status

0 references

on focus list of Wikimedia project

0 references

https://scigraph.springernature.com/pub.10.1186/1471-244x-12-24

0 references

Standards of medical care in diabetes--2012

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

6 September 2017

Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

6 September 2017

Risk of acute complications of diabetes among people with schizophrenia in Ontario, Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

6 September 2017

Physical health in schizophrenia: a challenge for antipsychotic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

6 September 2017

A healthy lifestyle intervention for middle-aged and older schizophrenia patients with diabetes mellitus: a 6-month follow-up analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

6 September 2017

Factors associated with work participation and work functioning in depressed workers: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

6 September 2017

Assessment of strategies for switching patients from olanzapine to risperidone: a randomized, open-label, rater-blinded study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

6 September 2017

Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

6 September 2017

Switching in the era of atypical antipsychotics. An updated review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

6 September 2017

Metabolic monitoring for patients treated with antipsychotic medications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

6 September 2017

Quality assessment of observational studies is not commonplace in systematic reviews

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

6 September 2017

Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

6 September 2017

A retrospective chart review of the clinical effects of atypical antipsychotic drugs on glycemic control in institutionalized patients with schizophrenia and comorbid diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

6 September 2017

Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

6 September 2017

Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

6 September 2017

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

6 September 2017

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

6 September 2017

Physical risk factors for neck pain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

6 September 2017

Mortality in a cohort of patients with schizophrenia: a record linkage study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

6 September 2017

Psychopharmacologic treatment of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

28 September 2017

Paxton house: integrating mental health and diabetes care for people with serious mental illnesses in a residential setting.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

31 August 2018

Swedish clinical guidelines--prevention and management of metabolic risk in patients with severe psychiatric disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

31 August 2018

Outcome evaluation of a structured educational wellness program in patients with severe mental illness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

31 August 2018

Evidence of exacerbated cognitive deficits in schizophrenia patients with comorbid diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

31 August 2018

Quality of diabetes care among adults with serious mental illness.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

31 August 2018

Doing my best: poverty and self-care among individuals with schizophrenia and diabetes mellitus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

31 August 2018

A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

31 August 2018

Risperidone alternative for a schizophrenic patient with olanzapine-exacerbated diabetic mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

31 August 2018

Disparities in diabetes care: impact of mental illness.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

31 August 2018

Diabetes knowledge among persons with serious mental illness and type 2 diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

31 August 2018

High-dose olanzapine-induced improvement of preexisting type 2 diabetes mellitus in schizophrenic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

31 August 2018

Management of diabetes mellitus occurring during treatment with olanzapine: report of six cases and clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

31 August 2018

Atypical antipsychotics and glycemia: a case report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

31 August 2018

Recovery from new-onset diabetes in a schizophrenic man after withdrawal of olanzapine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340308

31 August 2018

[HbA1c--the gold standard in the assessment of diabetes treatment?]

1 reference

https://pubmed.ncbi.nlm.nih.gov/22443212

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22443212

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-244X-12-24

1 reference

Europe PubMed Central

26 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

26 August 2017

1 reference

Europe PubMed Central

26 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37996445&oldid=2063155901"